Stroke Genetics: A Review and Update.
10.5853/jos.2014.16.3.114
- Author:
Arne LINDGREN
1
Author Information
1. Department of Clinical Sciences Lund, Neurology, Lund University, Lund, Sweden. arne.lindgren@med.lu.se
- Publication Type:Review
- Keywords:
Stroke;
Genetics;
Pharmacogenetics;
Genetic Association Studies;
Humans
- MeSH:
Atrial Fibrillation;
Brain Injuries;
Cerebral Hemorrhage;
Embolism;
Epigenomics;
Exome;
Genetic Association Studies;
Genetic Research;
Genetic Variation;
Genetics*;
Genome;
Genome-Wide Association Study;
Humans;
Hypertension;
Models, Theoretical;
Molecular Biology;
Pharmacogenetics;
Polymorphism, Single Nucleotide;
Prognosis;
RNA;
Stroke*
- From:Journal of Stroke
2014;16(3):114-123
- CountryRepublic of Korea
- Language:English
-
Abstract:
Stroke genetics includes several topics of clinical interest, including (1) molecular genetic variations affecting risk of monogenic stroke syndromes; (2) molecular genetic variations affecting risk of common stroke syndromes, sometimes with specific effects on risk of specific main types of stroke or subtypes of ischemic and hemorrhagic stroke; (3) genetics of conditions associated with stroke risk e.g. white matter hyperintensities, atrial fibrillation and hypertension; (4) hereditary causes of familial aggregation of stroke; (5) epigenetic impact on protein expression during acute brain injury; (6) genetic influence on stroke recovery; and (7) pharmacogenetics. Genetic research methods include candidate gene studies; Genome Wide Association Studies; family studies; RNA and protein analyses; and advanced computer-aided analytical methods to detect statistically significant associations. Several methods that could improve our knowledge of stroke genetics are being developed e.g.: Exome content analysis; Next-generation sequencing; Whole genome sequencing; and Epigenetics. During 2012-2014, several Single Nucleotide Polymorphisms (SNPs) have been related to common ischemic stroke risk. Certain SNPs have been associated with risk of specific ischemic stroke subtypes such as large vessel disease and cardiac embolism, particular subtypes of intracerebral hemorrhage (ICH), especially lobar ICH, and with prognosis after ICH. Large international studies on stroke recovery and exome content are ongoing. Advanced mathematical models have been used to study how several SNPs can act together and increase stroke risk burden. Such efforts require large numbers of patients and controls, which is achieved by co-operation in large international consortia such as the International Stroke Genetics Consortium. This overview includes an introduction to genetics, stroke genetics in general, and different genetic variations that may influence stroke risk. It presents some of the latest reports on stroke genetics published in high impact journals. The role of pharmacogenetics, the current clinical situation, and future prospects will also be discussed.
